Ticker League

Estimates for Palantir (PLTR)

Analyst consensus revenue & EPS estimates for Palantir (PLTR) — Q2 2026. Compare the numbers and make your own prediction.

Consensus EPS · Q2 2026

$0.35

Consensus revenue · Q2 2026

$1.8B

Analysts

17

Expected report

Aug 3, 2026

After close
Upcoming earnings
Locks in 11 days 9 hours · AMC: Locks at 4:00 PM ET on report day
Revenue$1.8B$1.8B $1.9B
EPS$0.35$0.33 $0.40

What to watch

  • Analyst ratings: Upgrades trending
Make your prediction

Analyst consensus

Based on estimates from 17 analysts.

  • Revenue$1.8B
  • EPS$0.35
  • EBITDA$432.1M
  • EBIT$392.3M
  • Net income$884.6M

Historical beat/miss

Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.

  • Q1 2026+5.9%+19.0%
  • Q4 2025+5.1%+8.6%

Estimate revisions

How analyst consensus estimates have changed over the past 90 days.

Collecting data

Revision trends appear once we have collected at least two daily snapshots for this period.

Community vs analysts

See how the TickerLeague crowd's forecast stacks up against Wall Street.

Be the first to predict

No community consensus for Palantir (PLTR) Q2 2026 yet. Make a prediction to start the crowd forecast.

Make your prediction

Analyst price target

Based on price targets from 1 analyst.

Low
$138.00
Consensus
$185.36
Median
$190.00
High
$230.00
Current
$124.57
Upside
+48.8%

Upside calculated vs most recent trading price of $124.57.

Consensus across all covering analysts. See the ranking ›

$185.36+48.80%

Analyst ratings

Consensus: Buy — based on 26 analyst ratings.

Buy 12Hold 11Sell 3

24-month trend

Recent analyst actions

  • Jul 17, 2026DA DavidsonBuy
  • Jul 2, 2026DA DavidsonBuy
  • Jun 16, 2026Wolfe ResearchPeer Perform
  • Jun 5, 2026WedbushOutperform
  • Jun 5, 2026RosenblattBuy
  • May 21, 2026RosenblattBuy
  • May 6, 2026CitigroupBuy
  • May 6, 2026Argus ResearchBuy
  • May 5, 2026WedbushOutperform
  • May 5, 2026RosenblattBuy

Frequently asked questions

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation